TrialsgrambetaRCTs are beautiful

EAST-AFNET 4

2020

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial

In 2,789 patients with early AF (≤ 1 yr), early rhythm-control therapy reduced CV death, stroke or hospitalisation for HF or ACS versus usual care.

Result

Efficacy: Composite CV death, stroke, HF/ACS hospHR 0.79

Below 1 favours early rhythm-control therapy, above 1 favours usual care.

Event rates Early rhythm-control therapy 3.9 vs usual care 5.0 per 100 patient-years

Original publication
Subtopic
Rate vs rhythm
Design
Open-label, blinded endpoint, median 5.1 yr
Relevance
Important: one of several pillars.
Source
Kirchhof P, et al. N Engl J Med. 2020;383(14):1305-1316.doi 10.1056/NEJMoa2019422

Discussion & critique

Reopened the rhythm-vs-rate question, but only for AF diagnosed in the last year. ~ 8 % had ablation by 2 yr; mostly drug-based.

Discussed in podcasts